Forex
Nurix Therapeutics Price Target Hiked to $36.00 by Royal Bank Of Canada
Nurix Therapeutics (NASDAQ:NRIX) received a boost to its price target from Royal Bank Of Canada, which increased it from $33.00 to $36.00 in a research report on Monday.
This increase represents a potential upside of 40.67% from the stock's current price and is part of a broader trend of analysts revising their price targets for NRIX.
Other firms, such as Mizuho and Robert W. Baird, have also raised their target prices on Nurix Therapeutics in recent weeks, with some assigning 'outperform' ratings to the stock.